Knowledge Base

Resources & Guides

Educational content about GLP-1 medications, pharmacokinetics, and optimizing your treatment journey.

Showing articles tagged: #diabetes Clear filter
// Individual Articles

Educational Content

View all →
Showing 9 of 9 articles
No articles found matching your search. Try a different term or view all articles.

Semaglutide Guide: Ozempic & Wegovy Complete Resource

hub

Everything you need to know about semaglutide (Ozempic/Wegovy): GLP-1 mechanism, FDA-approved dosing protocols, half-life pharmacokinetics, side effects, and our free calculator to track your journey.

GLP3 Planner •
Read more →
semaglutide ozempic wegovy glp-1 weight-loss diabetes novo-nordisk dosing half-life

Tirzepatide Dosage Chart 2026: Mounjaro & Zepbound Titration

guides

Complete tirzepatide dosage chart showing Mounjaro and Zepbound titration protocols week-by-week from 2.5mg to 15mg. Includes what to expect at each dose level, side effects by tier, printable download, and a free dosing calculator.

GLP3 Planner Team •
Read more →
tirzepatide mounjaro zepbound dosage chart dosing schedule titration printable reference glp-1 gip weight loss diabetes

Mounjaro vs Zepbound: Same Drug, Different Names (2026)

comparison

Mounjaro and Zepbound contain identical tirzepatide (LY3298176). The differences are indication, device, and insurance: not the molecule. Full comparison with cost data and decision framework.

GLP3 Planner Team •
Read more →
tirzepatide mounjaro zepbound comparison mounjaro vs zepbound same molecule tirzepatide brands eli lilly glp-1 gip dual-agonist weight loss diabetes

Tirzepatide Calculator & Guide: Mounjaro & Zepbound Dosing (2026)

hub

Free tirzepatide dosing calculator plus complete guide. Visualize Mounjaro/Zepbound drug levels, plan titration schedules, understand half-life pharmacokinetics, and manage side effects.

GLP3 Planner •
Read more →
tirzepatide mounjaro zepbound glp-1 gip dual-agonist weight-loss diabetes eli-lilly dosing tirzepatide calculator mounjaro calculator zepbound calculator

What Is Tirzepatide? GIP + GLP-1 Dual-Agonist Explained

article

Tirzepatide is a dual GIP/GLP-1 receptor agonist approved as Mounjaro (type 2 diabetes) and Zepbound (weight loss, sleep apnea). Clinical trials show up to 20.9% weight loss. This guide explains the science clearly.

GLP3 Planner •
Read more →
tirzepatide what is tirzepatide mounjaro zepbound dual agonist glp-1 gip weight loss mechanism of action eli lilly diabetes obesity

Ozempic vs Wegovy 2026: Cost, Dosing, Weight Loss Compared

comparison

Both Ozempic and Wegovy contain semaglutide, but Ozempic is FDA-approved for type 2 diabetes (max 1.0 mg) while Wegovy targets obesity (2.4 mg recommended maintenance, 7.2 mg maximum). Explore the differences.

GLP3 Planner Team •
Read more →
ozempic wegovy semaglutide glp-1 weight loss comparison diabetes obesity fda approval dosing

Semaglutide Dosage Chart: Ozempic vs Wegovy Titration Schedule (2026)

guides

Complete semaglutide dosage chart showing Ozempic (1.0 mg max) and Wegovy (2.4 mg maintenance, 7.2 mg max) titration protocols week-by-week. Includes what to expect at each dose level, side effects data, printable download, and a free dosing calculator.

GLP3 Planner Team •
Read more →
semaglutide ozempic wegovy dosage chart dosing schedule titration printable reference glp-1 weight loss diabetes

Semaglutide Side Effects: Ozempic, Wegovy & Rybelsus Complete Guide (2026)

guide

Semaglutide side effects guide: nausea, diarrhea, and GI symptoms from STEP and SUSTAIN trials, plus practical management tips.

GLP3 Planner •
Read more →
semaglutide ozempic wegovy rybelsus side effects nausea glp-1 weight-loss diabetes

Tirzepatide Side Effects: What to Expect & How to Manage (2026 Guide)

guide

Tirzepatide side effects guide: nausea, diarrhea, and other GI symptoms from clinical trial data, plus practical management tips.

GLP3 Planner •
Read more →
tirzepatide mounjaro zepbound side effects nausea glp-1 gip weight-loss diabetes